ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/10/01 | 4,580 | 4,665 | 4,570 | 4,625 | +95 | +2.1% | 910,900 |
2018/09/28 | 4,490 | 4,575 | 4,485 | 4,530 | +65 | +1.5% | 802,200 |
2018/09/27 | 4,520 | 4,570 | 4,465 | 4,465 | -40 | -0.9% | 733,100 |
2018/09/26 | 4,430 | 4,515 | 4,400 | 4,505 | +110 | +2.5% | 827,500 |
2018/09/25 | 4,265 | 4,415 | 4,255 | 4,395 | +130 | +3% | 759,500 |
2018/09/21 | 4,295 | 4,335 | 4,255 | 4,265 | +20 | +0.5% | 387,000 |
2018/09/20 | 4,225 | 4,260 | 4,200 | 4,245 | +25 | +0.6% | 371,700 |
2018/09/19 | 4,285 | 4,295 | 4,175 | 4,220 | -35 | -0.8% | 639,300 |
2018/09/18 | 4,105 | 4,280 | 4,080 | 4,255 | +150 | +3.7% | 722,400 |
2018/09/14 | 4,100 | 4,135 | 4,040 | 4,105 | +75 | +1.9% | 539,100 |
2018/09/13 | 4,000 | 4,115 | 3,965 | 4,030 | -20 | -0.5% | 657,700 |
2018/09/12 | 4,090 | 4,100 | 4,005 | 4,050 | -10 | -0.2% | 541,700 |
2018/09/11 | 3,950 | 4,065 | 3,915 | 4,060 | +80 | +2% | 575,100 |
2018/09/10 | 4,000 | 4,090 | 3,975 | 3,980 | -35 | -0.9% | 521,800 |
2018/09/07 | 4,050 | 4,100 | 3,985 | 4,015 | -115 | -2.8% | 638,400 |
2018/09/06 | 4,280 | 4,280 | 4,100 | 4,130 | -180 | -4.2% | 765,400 |
2018/09/05 | 4,355 | 4,370 | 4,285 | 4,310 | -60 | -1.4% | 505,900 |
2018/09/04 | 4,205 | 4,385 | 4,195 | 4,370 | +165 | +3.9% | 887,600 |
2018/09/03 | 4,270 | 4,310 | 4,175 | 4,205 | -135 | -3.1% | 679,100 |
2018/08/31 | 4,280 | 4,365 | 4,280 | 4,340 | +5 | +0.1% | 529,300 |
2018/08/30 | 4,350 | 4,365 | 4,300 | 4,335 | +10 | +0.2% | 601,500 |
2018/08/29 | 4,280 | 4,350 | 4,250 | 4,325 | +15 | +0.3% | 501,700 |
2018/08/28 | 4,285 | 4,370 | 4,265 | 4,310 | +45 | +1.1% | 648,200 |
2018/08/27 | 4,230 | 4,275 | 4,180 | 4,265 | +55 | +1.3% | 524,400 |
2018/08/24 | 4,210 | 4,255 | 4,155 | 4,210 | +45 | +1.1% | 730,800 |
2018/08/23 | 4,055 | 4,175 | 4,030 | 4,165 | +85 | +2.1% | 560,000 |
2018/08/22 | 3,980 | 4,150 | 3,930 | 4,080 | +125 | +3.2% | 1,143,400 |
2018/08/21 | 3,800 | 3,970 | 3,800 | 3,955 | +145 | +3.8% | 613,100 |
2018/08/20 | 3,885 | 3,920 | 3,780 | 3,810 | -15 | -0.4% | 617,900 |
2018/08/17 | 3,745 | 3,845 | 3,720 | 3,825 | +140 | +3.8% | 757,400 |
2018/08/16 | 3,730 | 3,775 | 3,625 | 3,685 | -95 | -2.5% | 869,600 |
2018/08/15 | 3,760 | 3,835 | 3,625 | 3,780 | +35 | +0.9% | 1,185,200 |
2018/08/14 | 3,935 | 3,935 | 3,715 | 3,745 | -155 | -4% | 1,539,700 |
2018/08/13 | 4,210 | 4,225 | 3,880 | 3,900 | -380 | -8.9% | 1,307,800 |
2018/08/10 | 4,420 | 4,440 | 4,265 | 4,280 | +105 | +2.5% | 1,384,600 |
2018/08/09 | 4,195 | 4,200 | 4,110 | 4,175 | -35 | -0.8% | 483,200 |
2018/08/08 | 4,155 | 4,235 | 4,155 | 4,210 | +75 | +1.8% | 485,200 |
2018/08/07 | 4,120 | 4,185 | 4,100 | 4,135 | +15 | +0.4% | 542,600 |
2018/08/06 | 4,110 | 4,175 | 4,090 | 4,120 | -10 | -0.2% | 638,300 |
2018/08/03 | 4,165 | 4,220 | 4,125 | 4,130 | -40 | -1% | 710,900 |
2018/08/02 | 4,175 | 4,210 | 4,080 | 4,170 | -20 | -0.5% | 871,500 |
2018/08/01 | 4,370 | 4,380 | 4,170 | 4,190 | -155 | -3.6% | 1,018,600 |
2018/07/31 | 4,350 | 4,385 | 4,290 | 4,345 | -35 | -0.8% | 683,400 |
2018/07/30 | 4,520 | 4,520 | 4,365 | 4,380 | -160 | -3.5% | 578,900 |
2018/07/27 | 4,500 | 4,555 | 4,470 | 4,540 | +45 | +1% | 524,500 |
2018/07/26 | 4,430 | 4,500 | 4,370 | 4,495 | +95 | +2.2% | 635,300 |
2018/07/25 | 4,385 | 4,405 | 4,330 | 4,400 | +15 | +0.3% | 443,600 |
2018/07/24 | 4,400 | 4,415 | 4,355 | 4,385 | -65 | -1.5% | 538,700 |
2018/07/23 | 4,435 | 4,470 | 4,385 | 4,450 | +25 | +0.6% | 431,000 |
2018/07/20 | 4,335 | 4,455 | 4,335 | 4,425 | +65 | +1.5% | 692,400 |
1651~
1700
件表示中 / 2952件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 157,100円 | +5.0% | +1.5% | 0.00% | 13.44倍 | 3.57倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 317,100円 | +8.0% | -15.3% | 3.91% | 8.90倍 | 0.86倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 184,000円 | +5.9% | +684.6% | 2.99% | 12.21倍 | 1.22倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 403,500円 | +3.6% | +6.1% | 2.97% | 13.60倍 | 0.80倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
市場注目の銘柄
該当銘柄がありません
チャート関連のコラム